Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FOLFOX in Irinotecan-Pretreated Metastatic Colorectal Cancer
NCT00016978Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Apr 2001
- Primary completion
- Jun 2007
- Modality
- DNA Intercalators/Alkylators
- Countries
- 2
01
Overview
A Phase 2 trial of oxaliplatin in colorectal cancer (CRC), sponsored by National Cancer Institute. Started Apr 2001; status: completed.
02
Drugs
oxaliplatin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on NCT00016978.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00016978.